Arkolith/Insider Trading/ANIK/Form 4

Blanchard Cheryl R

President, CEO, Director, DirectorAnika Therapeutics, Inc. (ANIK) · full profile →Form 4 · filed Mar 14, 2022
Net Buying
Open-Market Buys
$207K
Open-Market Sells
$0
Net Open-Market Flow
$207K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 11, 2022Buy(P)4K$25.36$109K56K
Mar 11, 2022Buy(P)4K$25.81$98K60K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001171843-22-001833) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML